BHV-3241 in Subjects with Multiple System Atrophy / Patient Care / Take Action / Find a Clinical Trial / Clinical Trials / BHV-3241 in Subjects with Multiple System AtrophyThe purpose of this study is to compare the efficacy of BHV-3241 versus placebo in subjects with multiple system atrophy.StatusOpen and enrolling subjects.LocationPhoenix, ArizonaAge Range40-75Total Participants250Keywordsmultiple system atrophyParkinson's diseasePrimary SponsorBiohaven Pharmaceuticals, Inc. Muhammad Ali Parkinson Center Muhammad Ali Parkinson Center Muhammad Ali Parkinson Center Call Us Enrollment InformationCall 1-877-287-7122 Call Us
